754 related articles for article (PubMed ID: 32359177)
1. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China.
Lei F; Liu YM; Zhou F; Qin JJ; Zhang P; Zhu L; Zhang XJ; Cai J; Lin L; Ouyang S; Wang X; Yang C; Cheng X; Liu W; Li H; Xie J; Wu B; Luo H; Xiao F; Chen J; Tao L; Cheng G; She ZG; Zhou J; Wang H; Lin J; Luo P; Fu S; Zhou J; Ye P; Xiao B; Mao W; Liu L; Yan Y; Liu L; Chen G; Li H; Huang X; Zhang BH; Yuan Y
Hepatology; 2020 Aug; 72(2):389-398. PubMed ID: 32359177
[TBL] [Abstract][Full Text] [Related]
2. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients.
Wang Q; Zhao H; Liu LG; Wang YB; Zhang T; Li MH; Xu YL; Gao GJ; Xiong HF; Fan Y; Cao Y; Ding R; Wang JJ; Cheng C; Xie W
Mil Med Res; 2020 Jun; 7(1):28. PubMed ID: 32507110
[TBL] [Abstract][Full Text] [Related]
3. Correlation analysis of coagulation dysfunction and liver damage in patients with novel coronavirus pneumonia: a single-center, retrospective, observational study.
Chen S; Liu H; Li T; Huang R; Gui R; Zhang J
Ups J Med Sci; 2020 Nov; 125(4):293-296. PubMed ID: 32990149
[TBL] [Abstract][Full Text] [Related]
4. Liver damage at admission is an independent prognostic factor for COVID-19.
Chen LY; Chu HK; Bai T; Tu SJ; Wei Y; Li ZL; Hu LL; Zhu R; Zhang L; Han CQ; Xiao L; He Q; Song J; Liu WH; Zhu QJ; Chen H; Yang L; Hou XH
J Dig Dis; 2020 Sep; 21(9):512-518. PubMed ID: 32713118
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.
Zhang H; Liao YS; Gong J; Liu J; Zhang H
World J Gastroenterol; 2020 Aug; 26(31):4694-4702. PubMed ID: 32884226
[TBL] [Abstract][Full Text] [Related]
6. The effect of liver test abnormalities on the prognosis of COVID-19.
Medetalibeyoglu A; Catma Y; Senkal N; Ormeci A; Cavus B; Kose M; Bayramlar OF; Yildiz G; Akyuz F; Kaymakoglu S; Tukek T
Ann Hepatol; 2020; 19(6):614-621. PubMed ID: 32920162
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of coronavirus disease 2019 patients complicated with liver injury.
Wen M; Lu J; Xie Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):555-559. PubMed ID: 32879106
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study.
Xie H; Zhao J; Lian N; Lin S; Xie Q; Zhuo H
Liver Int; 2020 Jun; 40(6):1321-1326. PubMed ID: 32239591
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].
Qian ZP; Mei X; Zhang YY; Zou Y; Zhang ZG; Zhu H; Guo HY; Liu Y; Ling Y; Zhang XY; Wang JF; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):229-233. PubMed ID: 32270660
[No Abstract] [Full Text] [Related]
10. Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin.
Li T; Guo Y; Zhuang X; Huang L; Zhang X; Wei F; Yang B
Saudi J Gastroenterol; 2020; 26(5):272-278. PubMed ID: 32769260
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China.
Wang M; Yan W; Qi W; Wu D; Zhu L; Li W; Wang X; Ma K; Ni M; Xu D; Wang H; Chen G; Yu H; Ding H; Xing M; Han M; Luo X; Chen T; Guo W; Xi D; Ning Q
Hepatol Int; 2020 Sep; 14(5):723-732. PubMed ID: 33026573
[TBL] [Abstract][Full Text] [Related]
13. COVID-19: Abnormal liver function tests.
Cai Q; Huang D; Yu H; Zhu Z; Xia Z; Su Y; Li Z; Zhou G; Gou J; Qu J; Sun Y; Liu Y; He Q; Chen J; Liu L; Xu L
J Hepatol; 2020 Sep; 73(3):566-574. PubMed ID: 32298767
[TBL] [Abstract][Full Text] [Related]
14. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.
Hundt MA; Deng Y; Ciarleglio MM; Nathanson MH; Lim JK
Hepatology; 2020 Oct; 72(4):1169-1176. PubMed ID: 32725890
[TBL] [Abstract][Full Text] [Related]
15. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
[TBL] [Abstract][Full Text] [Related]
16. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
17. Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.
Wu Y; Li H; Guo X; Yoshida EM; Mendez-Sanchez N; Levi Sandri GB; Teschke R; Romeiro FG; Shukla A; Qi X
Hepatol Int; 2020 Sep; 14(5):621-637. PubMed ID: 32710250
[TBL] [Abstract][Full Text] [Related]
18. Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients.
Kumar A; Kumar P; Dungdung A; Kumar Gupta A; Anurag A; Kumar A
Diabetes Metab Syndr; 2020; 14(6):1951-1954. PubMed ID: 33039937
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of severe cases with COVID-19: a meta-analysis.
Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
Kumar-M P; Mishra S; Jha DK; Shukla J; Choudhury A; Mohindra R; Mandavdhare HS; Dutta U; Sharma V
Hepatol Int; 2020 Sep; 14(5):711-722. PubMed ID: 32623633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]